Albany, New York (PRWEB) May 22, 2014 <\/p>\n
Gene therapy involves use of DNA as a pharmaceutical agent to treat diseases. It is one of the most important developments in the field of medicine that has potential to treat various lethal diseases such as HIV, cancer and cystic fibrosis. In the long run, biotechnology and clinical trial industries will benefit from developments in gene therapy and provide potential treatment solutions for various incurable diseases. <\/p>\n
Browse the full report - http:\/\/www.transparencymarketresearch.com\/gene-therapy-market.html<\/a>. <\/p>\n In the present scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development. However, gene therapy is highly dependent on the regulatory approvals and most of the products are currently in clinical trial phase. Most of these gene therapy products are for cancer and cardiovascular diseases, and are in Phase III\/ Phase II of clinical trials. <\/p>\n In addition, growing popularity of DNA vaccines boost advances in gene therapy and is likely to be practiced in clinics in the near future, with a number of therapy programs now in phase II\/III trials, showing promising results. <\/p>\n Get report sample - http:\/\/www.transparencymarketresearch.com\/sample\/sample.php?flag=B&rep_id=1838<\/a>. <\/p>\n Some of the major players operating in the market are AnGes MG, BioSante Pharmaceuticals, GenVec, Genzyme Corporation, Oxford BioMedica, Transgene, Urigen Pharmaceuticals and Vical. <\/p>\n This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:<\/p>\n This report provides comprehensive analysis of:<\/p>\n This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porters five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. <\/p>\n <\/p>\n More:<\/p>\n Global Gene Therapy Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Albany, New York (PRWEB) May 22, 2014 Gene therapy involves use of DNA as a pharmaceutical agent to treat diseases. Continue reading